| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |